Bioinformatics

Dr. Vitali's research currently focuses on the development of bioinformatics analysis to advance the prevention and treatment of age-associated neurodegenerative diseases. Dr. Vitali is an Assistant Professor of Neurology at the University of Arizona and work with the research group of Dr. Roberta Diaz Brinton where is the Director of Bioinformatics and a faculty member of the Center for Innovation in Brain Science (CIBS). She is a doctor of bioinformatics and bioengineering from the University of Pavia, Italy.

We are a plant genomics lab who specialize in whole genome sequencing and assembly; with analyses of structural variation, gene modeling and transcriptomes. Our work on major projects of rice, corn, barley, etc, allows us to share our technical expertise with other researchers. Our research in plant and animal genomes, at the whole genome and transcriptome levels, will impact successful genetic selections toward the goal of feeding the 9 billion people toward the year 2050. Keywords: "Genome Sequencing", "PacBio", "Structural Genomics", "Plant Genetics", "DNA Extraction"

Carol Soderlund, PhD, is an Associate Research Professor at the BIO5 Institute at the University of Arizona. While working on her PhD in Computer science in 1988, she collaborated with a biologist to develop one of the first gene prediction programs. She received a DOE Human Genome Distinguished Postdoctoral Fellowship hosted by Los Alamos National Laboratory, where she became involved with mapping the human genome. Her work continued at the Sanger Centre in the UK, which was on the forefront of sequencing the human genome. She developed the FPC software, which was used for mapping the human genome, and has since been the primary software package for mapping large genomes.Her primary research objective is to provide environments for biologists to run algorithms (both her own and existing software), with highly interactive graphics for query and display of the data and results. Towards this end, she has published seven software packages for various genomic problems, where the three most important are: (1) The FPC program mentioned above, which is still being used after its initial release 15 years ago and has been extended for next generation sequencing. (2) The SyMAP software for the computation, query and display for synteny for the comparison of plant genomes. (3) The Transcriptome Computational Workbench (TCW) for the analysis of the transcriptome across tissues or conditions, and across the species for finding shared and unique genes.Dr. Soderlund has published over 60 original research papers and 20 book chapters on a range of genomic problems. She has collaborated with a range of scientists on a variety of organisms and genomic problems, where the majority of the collaborations have been on mapping genomes and transcriptome analysis, but she has also been involved in metagenomics, sequencing, and host-pathogen interactions.

William Montfort, PhD, determines the atomic structures of proteins and seeks to understand how protein structure gives rise to protein function – both in vitro and in living cells. At their heart, the problems have a fundamental structure-function question, but also address questions of importance to human health. Approaches include X-ray crystallography, rapid kinetic measurements, spectroscopy, theory, protein expression, drug discovery, molecular genetics and related techniques.Dr. Montfort is particularly interested in nitric oxide signaling mechanisms. Nitric oxide (NO) is a small reactive molecule produced by all higher organisms for the regulation of an immensely varied physiology, including blood pressure regulation, memory formation, tissue development and programmed cell death. He is interested in two NO signaling mechanisms: binding of NO to heme and the nitrosylation (nitrosation) of cysteines. NO, produced by NO synthase, binds to soluble guanylate cyclase (sGC) at a ferrous heme center, either in the same cell or in nearby cells. Binding leads to conformational changes in heme and protein, and to induction of the protein’s catalytic function and the production cGMP. NO can also react with cysteine residues in proteins, giving rise to S-nitroso (SNO) groups that can alter protein function. He continues to study the mechanistic details surrounding cGMP and SNO production, and the signaling consequences of their formation.For reversible Fe-NO chemistry, Dr. Montfort is studying soluble guanylate cyclase and the nitrophorins, a family of NO transport proteins from blood-sucking insects. Our crystal structures of nitrophorin 4 extend to resolutions beyond 0.9 angstroms, allowing us to view hydrogens, multiple residue conformations and subtle changes in heme deformation. For reversible SNO chemistry, he is studying thioredoxin, glutathione S-nitroso reductase (GSNOR) and also sGC. For regulation in the cell, Dr. Montfort and his group have constructed a model cell system based on a human fibrosarcoma called HT-1080, where sGC, NO synthase, thioredoxin and GSNOR can be manipulated in a functional cellular environment. With these tools, they are exploring the molecular details of NO signaling and whole-cell physiology, and undertaking a program of drug discovery for NO-dependent diseases. Keywords: Structural Biology, Drug Discovery, Cancer, Cardiovascular Disease

Joanna Masel, D.Phil., is a Professor of Ecology & Evolutionary Biology, applying the tools of theoretical population genetics to diverse research problems. Her research program is divided between analytical theory, evolutionary simulations, and dry lab empirical bioinformatic work. The robustness and evolvability of living systems are major themes in her work, including questions about the origins of novelty, eg at the level of new protein-coding sequences arising during evolution from "junk" DNA. She also has interests in prion biology, and in the nature of both biological and economic competitions. She has won many awards, including a Fellowship at Wissenschaftskolleg zu Berlin, a Pew Scholarship in the Biomedical Sciences, an Alfred P. Sloan Research Fellow, a Rhodes Scholarship, and a Bronze Medal at the International Mathematical Olympiad.

John Kececioglu is an Associate Professor in the Department of Computer Science, and the BIO5 Institute. His research is in applied algorithms, especially for areas of bioinformatics and computational biology such as: multiple alignment, inverse alignment, sequence assembly, and genome rearrangement. Software developed by his group includes Opal, a tool for multiple sequence alignment; Facet, a tool for alignment accuracy estimation; Ipa, a tool for inverse sequence alignment; AlignAlign, a tool for optimally aligning alignments, and Ninja, a tool for evolutionary tree construction. John is a recipient of a National Science Foundation CAREER Award, serves as an Associate Editor for IEEE/ACM Transactions on Computational Biology and Bioinformatics, and is on the Editorial Board of Algorithms for Molecular Biology. He was Conference Chair for RECOMB 2009, and Program Committee Co-Chair in the area of Sequence Analysis for ISMB 2011 and BCB 2012. John served as Associate Head of the Department of Computer Science during 2012.

Dr. Bonnie Hurwitz is an Assistant Professor of Biosystems Engineering at the University of Arizona and BIO5 Research Institute Fellow. She has worked as a computational biologist for nearly two decades on interdisciplinary projects in both industry and academia. Her research on the human/earth microbiome incorporates large-scale –omics datasets, high-throughput computing, and big data analytics towards research questions in “One Health”. In particular, Dr. Hurwitz is interested in the relationship between the environment, microbial communities, and their hosts. Dr. Hurwitz is well-cited for her work in computational biology in diverse areas from plant genomics to viral metagenomics with over 1200 citations

I am a senior research scientist and oversees medicinal chemistry research at BIO5 Institute's drug discovery initiative. I oversee group of medicinal chemistry involved in the development of small molecule therapeutics for idiopathic pulmonary fibrosis (IPF), neuropathic pain, acute lung injury and cancer. I am co-founder of Reglagene and Regulonix - two biotech companies with startup technology from the University of Arizona. I have 15 years' experience in medicinal chemistry with expertise in translational drug development. I am also a co-inventor of small molecules targeting hTERT and MYC for the treatment of glioblastoma, melanoma, lymphomas and prostate cancer. Our work in the area of neuropathic pain has led to successful funding from Tech Launch Arizona and will result in STTR funding from NIH.

Matthew Cordes, Ph.D. is an Associate Professor of Chemistry and Biochemistry at the University of Arizona College of Science. Dr. Cordes’ research focuses on the origin and evolution of new protein structures and functions. He has published approximately 30 original research papers and presents his work frequently at national meetings such as the Protein Society and Gordon Research Conferences on Proteins and Biopolymers. Dr. Cordes’ primary research contributions are in four fields of protein evolution. First, his laboratory has identified cases in which a new type of protein structure has evolved from a preexisting structure. Second, he has identified evolutionary codes by which proteins that bind specific sites on double-stranded DNA evolve to recognize new target sites. Third, he studies the evolution of proteins in bloodsucking insects and spiders that affect blood homeostasis or cause dermonecrotic effects in mammalian tissue. Finally, he uses bioinformatics to identify hidden patterns in protein sequences that allow them to fold correctly and avoid aggregation such as that which occurs in Alzheimer’s disease. Dr. Cordes presently holds a BIO5 pilot project seed grant to study the evolution of enzyme toxins in brown spider venom.

Michael Barker is an evolutionary biologist studying the origins of biological diversity, particularly how abrupt genomic changes such as polyploidy, chromosomal change, and hybridization have contributed to the evolution of plant diversity. Biologists have long been fascinated by these processes because they create unique opportunities for the evolution of ecological and phenotypic novelty with the potential for relatively rapid speciation. Although assessing the importance of these abrupt changes has historically been a difficult task, advances in genomics and bioinformatics have created new opportunities for addressing these longstanding questions. By integrating new computational and evolutionary genomic tools with traditional approaches such as molecular evolution, phylogenetics, mathematical modeling, and experimental work Barker's lab currently studies 1.) the contributions of recent and ancient polyploidy to eukaryotic diversity; 2.) the evolution of chromosome number and genome organization; and 3.) the impact of hybridization on speciation and novelty.